Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
1984.
Parkinson's Disease, 1984.
The Lancet,
Vol. 323,
Issue. 8381,
p.
829.
Schwartzman, Robert Jay
and
Alexander, Guillermo M.
1985.
Changes in the local cerebral metabolic rate for glucose in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) primate model of Parkinson's disease.
Brain Research,
Vol. 358,
Issue. 1-2,
p.
137.
Martin, W. R. Wayne
1985.
Positron Emission Tomography in Movement Disorders.
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques,
Vol. 12,
Issue. 1,
p.
6.
Crossman, A.R.
Mitchell, I.J.
and
Sambrook, M.A.
1985.
Regional brain uptake of 2-deoxyglucose in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)—induced parkinsonism in the macaque monkey.
Neuropharmacology,
Vol. 24,
Issue. 6,
p.
587.
Newman, Richard P.
and
Calne, Donald B.
1986.
Movement Disorders.
p.
39.
Cummings, J. L.
1986.
Subcortical Dementia Neuropsychology, Neuropsychiatry, and Pathophysiology.
British Journal of Psychiatry,
Vol. 149,
Issue. 6,
p.
682.
McGeer, E.G.
McGeer, P.L.
Kamo, H.
Tago, H.
and
Harrop, R.
1986.
Cortical Metabolism, Acetylcholinesterase Staining and Pathological Changes in Alzheimers Disease.
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques,
Vol. 13,
Issue. S4,
p.
511.
Schuier, F. J.
1987.
Clinical efficacy of positron emission tomography.
p.
93.
Crossman, A.R.
1987.
Primate models of dyskinesia: The experimental approach to the study of basal ganglia-related involuntary movement disorders.
Neuroscience,
Vol. 21,
Issue. 1,
p.
1.
Wayne Martin, W.R.
1987.
The contribution of pet scanning to understanding metabolism and drug actions in the basal ganglia.
Pharmacology & Therapeutics,
Vol. 32,
Issue. 1,
p.
77.
Montastruc, J. L.
Celsis, P.
Agniel, A.
Demonet, J. F.
Doyon, B.
Puel, M.
Marc‐Vergnes, J. P.
and
Rascol, A.
1987.
Levodopa‐induced regional cerebral blood flow changes in normal volunteers and patients with Parkinson's disease.
Movement Disorders,
Vol. 2,
Issue. 4,
p.
279.
Peppard, R. F.
and
Calne, D. B.
1987.
Modification of Cell to Cell Signals During Normal and Pathological Aging.
p.
235.
Pizzolato, G.
Dam, M.
Borsato, N.
Saitta, B.
Da Col, C.
Perlotto, N.
Zanco, P.
Ferlin, G.
and
Battistin, L.
1988.
[99mTc]-HM-PAO SPECT in Parkinson's Disease.
Journal of Cerebral Blood Flow & Metabolism,
Vol. 8,
Issue. 1_suppl,
p.
S101.
Perlmutter, Joel S.
1988.
New insights into the pathophysiology of Parkinson's disease: the challenge of positron emission tomography.
Trends in Neurosciences,
Vol. 11,
Issue. 5,
p.
203.
Crossman, A.R
1989.
Neural mechanisms in disorders of movement.
Comparative Biochemistry and Physiology Part A: Physiology,
Vol. 93,
Issue. 1,
p.
141.
Wooten, G. Frederick
and
Trugman, Joel M.
1989.
The dopamine motor system.
Movement Disorders,
Vol. 4,
Issue. S1,
p.
S38.
Dubinsky, Richard M.
Baker, Michael
Hallett, Mark
Greenberg, Michael
and
di Chiro, Giovanni
1989.
Hemiballismus: Study of a case using positron emission tomography with 18f1uoro‐2‐deoxyg1ucose.
Movement Disorders,
Vol. 4,
Issue. 4,
p.
310.
Martin, W. R. Wayne
1989.
Imaging techniques in Parkinson's disease.
Movement Disorders,
Vol. 4,
Issue. S1,
p.
S63.
Martin, W. R. W.
1989.
Drugs for the Treatment of Parkinson’s Disease.
Vol. 88,
Issue. ,
p.
165.
Huber, M.
Herholz, K.
Holthoff, V.
and
Heiss, W.-D.
1989.
Early Diagnosis and Preventive Therapy in Parkinson’s Disease.
p.
125.